Viewing Study NCT01030302

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2026-06-25 @ 1:03 AM
Study NCT ID: NCT01030302
Status: COMPLETED
Last Update Posted: 2013-03-08
First Post: 2009-10-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Retreatment Study With Bortezomib for Multiple Myeloma
Sponsor: Janssen Korea, Ltd., Korea
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bortezomib retreatment View
None Velcade View
None Proteasome inhibitor View
None Bortezomib View